Autopsy report · NCT02042053

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

“Due to PI leaving the institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

PET/CT; PET/MRI

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• SCD Fit Homebase Program
  “PI leaving institution” (93% match in meaning)
• A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney Disease
  “The PI is leaving the institution” (92% match in meaning)
• Hemodynamic Effects Of Impella On Renal Circulation And Risk Of CA-AKI Among Patients Undergoing Protected PCI
  “PI may be leaving the institution” (92% match in meaning)
• Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease
  “PI left the institution” (91% match in meaning)
• Impact of Strength and Power Training on Golf Performance and Swing Biomechanics
  “PI has left the institution.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.